DTL
CBAY

Dynamic Technology Lab’s Cymabay Therapeutics CBAY Stock Holding History

Dynamic Technology Lab’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-27,458
Closed -$409K – 1481
2023
Q3 		$409K Buy
+27,458
New +$364K 0.04% 558
2022
Q4 		– Sell
-10,094
Closed -$35K – 1616
2022
Q3 		$35K Buy
+10,094
New +$36.3K ﹤0.01% 1069
2022
Q1 		– Sell
-11,074
Closed -$37K – 1624
2021
Q4 		$37K Buy
+11,074
New +$42K ﹤0.01% 1071
2021
Q1 		– Sell
-22,810
Closed -$131K – 1563
2020
Q4 		$131K Buy
+22,810
New +$173K 0.02% 890
2020
Q2 		– Sell
-17,580
Closed -$26K – 1430
2020
Q1 		$26K Buy
+17,580
New +$29.5K 0.01% 964

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dynamic Technology Lab's CBAY Position: Q4 2023 in Review

Dynamic Technology Lab sold out of Cymabay Therapeutics (CBAY) in Q4 2023, closing a stake of 27,458 shares — an estimated $409K sold.

Dynamic Technology Lab first reported a position in CBAY in Q1 2020 and held it in 5 quarters. The position peaked at $409K in Q3 2023. 200 funds tracked by Wall St. Rank hold CBAY as of Q4 2023.

  • Dynamic Technology Lab reported no remaining Cymabay Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 27,458 Cymabay Therapeutics shares in Q4 2023, an estimated $409K.
  • Dynamic Technology Lab first reported a position in Cymabay Therapeutics in Q1 2020 and held it in 5 quarters.
  • Dynamic Technology Lab's Cymabay Therapeutics position peaked at $409K in Q3 2023.
  • 200 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q4 2023.

Based on Dynamic Technology Lab's 13F filing for Q4 2023, filed 9 Feb 2024.